Alfonsi P.Postanaesthetic shivering. Epidemiology, path-ophysiology and approaches to prevention and management[J].Minerva Anesthesiologica.2003,69(5):438-441.
[2]
Lee L HY, Irwin MG, Yao TJ, et al. Timing of intraoperative parecoxib analgesia in colorectal surgery[J].Acute Pain, 2008,10(3):123-130.
Hubbard RC, Naumann TM,Traylor L, et al.Parecoxib sodium has opioid-sparing effects in patients undergoing total knee arthroplasty under spinal anaesthesia [J]. Br J Anaesth, 2003,90(2):166-172.
[7]
Malan TP Jr, Marsh G, Hakki Sl, et al. Parecoxib sodium,a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty [J]. Anesthesiology, 2003,98(4):950-956.
Brune K,Hintz B.Selective cyclooxygenase-2 inhibitors:similarities and differences[J].Scand J Rheumatol,2004,33:1-6.
[11]
Nussmeier NA, Whelton AA, Brown MT, et al. Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgery [J]. Anesthesiology, 2006, 104(3):518-526.
